Skip to content

Fresenius Kabi

Active
Public limited companyfounded 1996active for 30 yearsBrandekensweg 9, 2627 Schelle, Belgium12 active companies are registered at this addressKBO/BCE: BE 0458.813.760
Summary

Fresenius Kabi has been active since 1996 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €29.9m and a net result of €3.9m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 37% of 6,141 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
Fresenius KabiActiveChecked score 88/100
Risk analysis ReportCompare

Overview

Activity
Wholesale of pharmaceutical and medical goods
NACE 46460
Largest employer in Schelle, Wholesale and retail trade sector1 site
Size
€78.3mturnover 2025
Staff
60.8 FTE
Equity
€29.9m
Profit
€3.9m
Financial health
88 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Parent
Fresenius Kabi Grupo España BV · 100%
Auditor: BV PwC Bedrijfsrevisoren2025 accounts 25 days early6 of 23 deeds summarised
Why 88raises riskLiquidity: current ratio 1.49lowers riskFounded in 1996Size: turnover €78.3m, 60.8 FTE, total assets €90.3mLegal form: public limited companyShow the evidence

Checked score

Score 2025
88 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 45% of its sector peers (NACE 46, medium-sized)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Average
Solvency 58-14
equity 33.1% of total assets
Liquidity 31+7
short-term debt 65.3%
Profitability 63+4
return on assets 4.3%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.2% (746 companies, NACE 46, medium-sized)
Last 24 months 11-2024: 0.2%highest value 12-2024: 0.2%● unchanged vs 11-2024highest value 01-2025: 0.2%● unchanged vs 12-2024highest value 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025 07-2025: 0.1%▼ -0.1 percentage points vs 06-2025lowest value 08-2025: 0.1%● unchanged vs 07-2025lowest value 09-2025: 0.1%● unchanged vs 08-2025lowest value 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €2,600,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.49, compared with 1.89 in 2024, below the usual 1.5; short-term debt: 65.3% of total assets), and 66.9% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, medium-sized): better than 42% on solvency, 36% on liquidity, 57% on profitability and 46% on growth.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Liquidity: current ratio 1.49
NBB · annual accounts
lowers risk · Founded in 1996
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
lowers risk · Size: turnover €78.3m, 60.8 FTE, total assets €90.3m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Legal form: public limited company
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
25 days early
2024
42 days early
2023
49 days early
2022
52 days early
2021
58 days late
2020
3 days early
2019
39 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 11 days before the deadline; the sector median (NACE 46) for financial year 2024 is 3 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 19 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Reappointment: PwC Bedrijfsrevisoren BV (statutory auditor)Permanent representative: Didier Delanoye
  2. Annual accounts filedfinancial year 2025 · full…
  3. Resignations: Ramona Maes (director) and Yenna…Appointments: Yenna Vandevijver (gecoöpteerde bestuurder)…

Key points

  • Positive: Largest employer in Schelle, Wholesale and retail trade sectorin the Checked rankings No. 1 View
  • Positive: 7 years of growth in a rowturnover 2025: €78.3m 7 years View
  • Controlled by Fresenius Kabi Grupo España…ultimately: Fresenius SE & Co… 100% View
  • Positive: Result rose in 2025from €2.7m to €3.9m ▲ 44.3% View
  • New directorslatest change 09-01-2026 · 3 in office 2 joined View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View

By topic

Financials

Financial year
2025
Turnover
€78.3m
Profit
€3.9m
Solvency
33.1%
Turnover▲ 11.9%
Net result
20182025
Go to Financials

Board & ownership

Board
3 members
Parent
Fresenius Kabi Grupo España… · 100%
Auditor
BV PwC Bedrijfsrevisoren
  • Metje Miranda HeiningManaging director
  • Bruno Alexandre Mendes Da SilvaDirector
  • Yenna VandevijverDirector
Go to Board & ownership

Timeline

Events
40
Since
1997
Next accounts
by 31-07-2027
  1. 31-12-2025Highest result from 2018 to 2025
  2. 19-06-2025Annual accounts filed
  3. 11-09-2024Reappointment: Metje Miranda Heining (director)
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Founded
18-09-1996
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
24
Annual meeting
First Tuesday of June
Purpose
“De fabricage van en de handel in - zowel in binnen- als buitenland - medische artikelen…” (deed in Dutch)
Go to Articles of association

Key facts about Fresenius Kabi

What is the company number of Fresenius Kabi?
0458.813.760. In Belgium the VAT number is the company number with BE in front: BE 0458.813.760.
Where is Fresenius Kabi based?
The registered office is at Brandekensweg 9, 2627 Schelle.Company details
What does Fresenius Kabi do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of Fresenius Kabi?
Public limited company (NV).
When was Fresenius Kabi founded?
On 18-09-1996.
Is Fresenius Kabi still active?
Yes, Fresenius Kabi is an active enterprise in the KBO register.
How many employees does Fresenius Kabi have?
On average 60.8 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Fresenius Kabi?
€78.3m in financial year 2025, according to the filed annual accounts.
Is Fresenius Kabi profitable?
In financial year 2025, Fresenius Kabi made a profit of €3.9m.
Where can I find the annual accounts of Fresenius Kabi?
Fresenius Kabi filed 30 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Fresenius Kabi due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Fresenius Kabi

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure